A model-based tool for guiding infliximab induction dosing to maximise long-term deep remission in children with inflammatory bowel diseases.

Wannee KantasiripitakSebastian G WichaDebby ThomasIlse HoffmanMarc FerranteSéverine VermeireKaren van HoeveErwin Dreesen

Published in: Journal of Crohn's & colitis (2023)

A freely available, multi-model MIPD tool facilitates infliximab induction dosing and improves deep remission rates in children with IBD.

Keyphrases